Skip to main content
PMC home page
The BMJ logoLink to The BMJ
. 1996 Dec 14;313(7071):1507–1512. doi: 10.1136/bmj.313.7071.1507

Malignant cerebral glioma--I: Survival, disability, and morbidity after radiotherapy.

E Davies 1, C Clarke 1, A Hopkins 1
PMCID: PMC2353065  PMID: 8978224

Abstract

OBJECTIVE: To describe survival, disability, and morbidity after radiotherapy for malignant glioma. DESIGN: Two year prospective study with home interviews with patients and relatives. SETTING: Seven neurosurgical and radiotherapy centres in London. SUBJECTS: 105 patients aged 21 to 75: 59 had biopsy; 46 had partial macroscopic resection; 92 received radiotherapy; and 13 received steroids alone. MAIN OUTCOME MEASURES: Survival, time free from disability, and changes in disability after treatment. RESULTS: Six and 12 month survival for radiotherapy patients was 70% and 39%, respectively. Age, World Health Organisation clinical performance status, extent of surgery, and history of seizures before diagnosis each influenced survival. The Medical Research Council prognostic index was also significantly related to survival. Multivariate analysis showed that initial clinical performance status was the most important component of the index. Most (80%; 49/61) patients with a clinical performance status of 0, 1, or 2 lived at least six months before becoming permanently disabled. Most patients who had initially had a good clinical performance status (0-2) and who were alive six months after radiotherapy (68%; 36/52), however, had experienced either clinical deterioration or severe tiredness after treatment. In 17% (9/52) of these some permanent loss of function remained. These adverse effects were associated with increasing radiotherapy dose. Severely disabled patients (clinical performance status 3 or 4) gained little benefit. CONCLUSION: Severely disabled patients gain little physical benefit from radiotherapy, whereas those not so disabled may experience considerable adverse effects.

Full text

PDF
1507

Images in this article

1508Fig 1
on p.1508
1508Fig 2
on p.1508

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bleehen N. M., Stenning S. P. A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. The Medical Research Council Brain Tumour Working Party. Br J Cancer. 1991 Oct;64(4):769–774. doi: 10.1038/bjc.1991.396. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brada M. Back to the future--radiotherapy in high grade gliomas. Br J Cancer. 1989 Jul;60(1):1–4. doi: 10.1038/bjc.1989.207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Burger P. C., Green S. B. Patient age, histologic features, and length of survival in patients with glioblastoma multiforme. Cancer. 1987 May 1;59(9):1617–1625. doi: 10.1002/1097-0142(19870501)59:9<1617::aid-cncr2820590916>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  4. Chang C. H., Horton J., Schoenfeld D., Salazer O., Perez-Tamayo R., Kramer S., Weinstein A., Nelson J. S., Tsukada Y. Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study. Cancer. 1983 Sep 15;52(6):997–1007. doi: 10.1002/1097-0142(19830915)52:6<997::aid-cncr2820520612>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  5. Choucair A. K. Proposals for evaluation of toxic effects associated with treatment of gliomas: a call for action. J Natl Cancer Inst. 1990 Mar 21;82(6):531–532. doi: 10.1093/jnci/82.6.531. [DOI] [PubMed] [Google Scholar]
  6. Daumas-Duport C., Scheithauer B., O'Fallon J., Kelly P. Grading of astrocytomas. A simple and reproducible method. Cancer. 1988 Nov 15;62(10):2152–2165. doi: 10.1002/1097-0142(19881115)62:10<2152::aid-cncr2820621015>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  7. Davies E., Clarke C., Hopkins A. Malignant cerebral glioma--II: Perspectives of patients and relatives on the value of radiotherapy. BMJ. 1996 Dec 14;313(7071):1512–1516. doi: 10.1136/bmj.313.7071.1512. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Freeman J. E., Johnston P. G., Voke J. M. Somnolence after prophylactic cranial irradiation in children with acute lymphoblastic leukaemia. Br Med J. 1973 Dec 1;4(5891):523–525. doi: 10.1136/bmj.4.5891.523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gibberd F. B., Scott G. M. Morbidity in patients with intracranial gliomas. J Neurol Neurosurg Psychiatry. 1983 May;46(5):460–460. doi: 10.1136/jnnp.46.5.460. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Green S. B., Byar D. P., Walker M. D., Pistenmaa D. A., Alexander E., Jr, Batzdorf U., Brooks W. H., Hunt W. E., Mealey J., Jr, Odom G. L. Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma. Cancer Treat Rep. 1983 Feb;67(2):121–132. [PubMed] [Google Scholar]
  11. Hutton J. L., Smith D. F., Sandemann D., Foy P. M., Shaw M. D., Williams I. R., Chadwick D. W. Development of prognostic index for primary supratentorial intracerebral tumours. J Neurol Neurosurg Psychiatry. 1992 Apr;55(4):271–274. doi: 10.1136/jnnp.55.4.271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kristiansen K., Hagen S., Kollevold T., Torvik A., Holme I., Nesbakken R., Hatlevoll R., Lindgren M., Brun A., Lindgren S. Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Study Group. Cancer. 1981 Feb 15;47(4):649–652. doi: 10.1002/1097-0142(19810215)47:4<649::aid-cncr2820470405>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  13. Leibel S. A., Sheline G. E. Radiation therapy for neoplasms of the brain. J Neurosurg. 1987 Jan;66(1):1–22. doi: 10.3171/jns.1987.66.1.0001. [DOI] [PubMed] [Google Scholar]
  14. Pickard J. D., Bailey S., Sanderson H., Rees M., Garfield J. S. Steps towards cost-benefit analysis of regional neurosurgical care. BMJ. 1990 Sep 29;301(6753):629–635. doi: 10.1136/bmj.301.6753.629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Robinson R. Cost-benefit analysis. BMJ. 1993 Oct 9;307(6909):924–926. doi: 10.1136/bmj.307.6909.924. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Sheline G. E., Wara W. M., Smith V. Therapeutic irradiation and brain injury. Int J Radiat Oncol Biol Phys. 1980 Sep;6(9):1215–1228. doi: 10.1016/0360-3016(80)90175-3. [DOI] [PubMed] [Google Scholar]
  17. Thomas D. G., Nouby R. M. Experience in 300 cases of CT-directed stereotactic surgery for lesion biopsy and aspiration of haematoma. Br J Neurosurg. 1989;3(3):321–325. doi: 10.3109/02688698909002810. [DOI] [PubMed] [Google Scholar]
  18. Todd N. V., McDonagh T., Miller J. D. What follows diagnosis by computed tomography of solitary brain tumour? Audit of one year's experience in South East Scotland. Lancet. 1987 Mar 14;1(8533):611–612. doi: 10.1016/s0140-6736(87)90244-3. [DOI] [PubMed] [Google Scholar]
  19. Walker M. D., Alexander E., Jr, Hunt W. E., MacCarty C. S., Mahaley M. S., Jr, Mealey J., Jr, Norrell H. A., Owens G., Ransohoff J., Wilson C. B. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J Neurosurg. 1978 Sep;49(3):333–343. doi: 10.3171/jns.1978.49.3.0333. [DOI] [PubMed] [Google Scholar]
  20. Walker M. D., Green S. B., Byar D. P., Alexander E., Jr, Batzdorf U., Brooks W. H., Hunt W. E., MacCarty C. S., Mahaley M. S., Jr, Mealey J., Jr Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med. 1980 Dec 4;303(23):1323–1329. doi: 10.1056/NEJM198012043032303. [DOI] [PubMed] [Google Scholar]
  21. Wroe S. J., Foy P. M., Shaw M. D., Williams I. R., Chadwick D. W., West C., Towns G. Differences between neurological and neurosurgical approaches in the management of malignant brain tumours. Br Med J (Clin Res Ed) 1986 Oct 18;293(6553):1015–1018. doi: 10.1136/bmj.293.6553.1015. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES